220 related articles for article (PubMed ID: 20497254)
1. Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L.
Konjar S; Sutton VR; Hoves S; Repnik U; Yagita H; Reinheckel T; Peters C; Turk V; Turk B; Trapani JA; Kopitar-Jerala N
Immunology; 2010 Oct; 131(2):257-67. PubMed ID: 20497254
[TBL] [Abstract][Full Text] [Related]
2. Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells.
Prunk M; Nanut MP; Sabotic J; Svajger U; Kos J
Radiol Oncol; 2019 Mar; 53(1):57-68. PubMed ID: 30840596
[TBL] [Abstract][Full Text] [Related]
3. Human CD4+ T-Cell Clone Expansion Leads to the Expression of the Cysteine Peptidase Inhibitor Cystatin F.
Perišić Nanut M; Pawelec G; Kos J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445118
[TBL] [Abstract][Full Text] [Related]
4. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
5. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity.
Sutton VR; Brennan AJ; Ellis S; Danne J; Thia K; Jenkins MR; Voskoboinik I; Pejler G; Johnstone RW; Andrews DM; Trapani JA
FEBS J; 2016 Mar; 283(5):947-61. PubMed ID: 26756195
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection.
Smyth MJ; Street SE; Trapani JA
J Immunol; 2003 Jul; 171(2):515-8. PubMed ID: 12847210
[TBL] [Abstract][Full Text] [Related]
7. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain.
Uellner R; Zvelebil MJ; Hopkins J; Jones J; MacDougall LK; Morgan BP; Podack E; Waterfield MD; Griffiths GM
EMBO J; 1997 Dec; 16(24):7287-96. PubMed ID: 9405358
[TBL] [Abstract][Full Text] [Related]
8. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function.
Voskoboinik I; Sutton VR; Ciccone A; House CM; Chia J; Darcy PK; Yagita H; Trapani JA
Blood; 2007 Aug; 110(4):1184-90. PubMed ID: 17475905
[TBL] [Abstract][Full Text] [Related]
9. Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia.
Shivakumar P; Mourya R; Bezerra JA
J Hepatol; 2014 Feb; 60(2):370-6. PubMed ID: 24096050
[TBL] [Abstract][Full Text] [Related]
10. NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells.
Vicioso Y; Wong DP; Roy NK; Das N; Zhang K; Ramakrishnan P; Parameswaran R
Front Immunol; 2021; 12():652786. PubMed ID: 33995369
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells.
Baran K; Ciccone A; Peters C; Yagita H; Bird PI; Villadangos JA; Trapani JA
J Biol Chem; 2006 Oct; 281(41):30485-91. PubMed ID: 16914553
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic activation of the cytotoxic phenotype during human NK cell development.
Meade JL; Wilson EB; Holmes TD; de Wynter EA; Brett P; Straszynski L; Ballard PA; Trapani JA; McDermott MF; Cook GP
J Immunol; 2009 Jul; 183(2):803-13. PubMed ID: 19570824
[TBL] [Abstract][Full Text] [Related]
14. Cystatin F regulates proteinase activity in IL-2-activated natural killer cells.
Maher K; Konjar S; Watts C; Turk B; Kopitar-Jerala N
Protein Pept Lett; 2014; 21(9):957-65. PubMed ID: 24702263
[TBL] [Abstract][Full Text] [Related]
15. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation.
Balaji KN; Schaschke N; Machleidt W; Catalfamo M; Henkart PA
J Exp Med; 2002 Aug; 196(4):493-503. PubMed ID: 12186841
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).
Stout-Delgado HW; Getachew Y; Miller BC; Thiele DL
J Immunol; 2007 Nov; 179(10):6561-7. PubMed ID: 17982045
[TBL] [Abstract][Full Text] [Related]
18. Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis.
Sutton VR; Waterhouse NJ; Browne KA; Sedelies K; Ciccone A; Anthony D; Koskinen A; Mullbacher A; Trapani JA
J Cell Biol; 2007 Feb; 176(4):425-33. PubMed ID: 17283185
[TBL] [Abstract][Full Text] [Related]
19. Killing by cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation.
Trapani JA; Smyth MJ
Immunol Cell Biol; 1993 Jun; 71 ( Pt 3)():201-8. PubMed ID: 8349302
[TBL] [Abstract][Full Text] [Related]
20. Cystatin F as a regulator of immune cell cytotoxicity.
Kos J; Nanut MP; Prunk M; Sabotič J; Dautović E; Jewett A
Cancer Immunol Immunother; 2018 Dec; 67(12):1931-1938. PubMed ID: 29748898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
